Genetics of vascular dementia – review from the ICVD working group

[1]  A. Thiel,et al.  Neuroimaging in vascular cognitive impairment: a state-of-the-art review , 2016, BMC Medicine.

[2]  J. Attems,et al.  Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group , 2016, BMC Medicine.

[3]  M. Munafo,et al.  A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort. , 2016, Journal of Alzheimer's disease : JAD.

[4]  Jean-François Dartigues,et al.  Edinburgh Research Explorer Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies , 2022 .

[5]  J. Lee,et al.  Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study , 2016, The Lancet Neurology.

[6]  J. Maguire.  NINDS Stroke Genetics Network (SiGN) and International Stroke Genetics Consortium (ISGC)., Attia, J. R., & Holliday, E. (2015) Loci associated with ischaemic stroke and its subtypes (SiGN): A genome-wide association study. Lancet Neurology, 174-184. doi:10.1016/S1474-4422(15)00338-5 , 2016 .

[7]  Kaitlin M. Fitzpatrick,et al.  Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke , 2016, Neurology.

[8]  Sui-qing Mi,et al.  Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta‐analysis of Clinical Trials , 2015, Phytotherapy research : PTR.

[9]  Benjamin F. J. Verhaaren,et al.  White Matter Lesion Progression: Genome-Wide Search for Genetic Influences , 2015, Stroke.

[10]  M. Tamura,et al.  Characteristic features and progression of abnormalities on MRI for CARASIL , 2015, Neurology.

[11]  H. Markus,et al.  Monogenic causes of stroke: now and the future , 2015, Journal of Neurology.

[12]  I. Alonso,et al.  Shifting the CARASIL Paradigm: Report of a Non-Asian Family and Literature Review , 2015, Stroke.

[13]  L. Pantoni,et al.  Next generation sequencing for systematic assessment of genetics of small-vessel disease and lacunar stroke. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[14]  Lorna M. Lopez,et al.  Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI , 2015, Circulation. Cardiovascular genetics.

[15]  田原 康玄,et al.  生活習慣病とgenome-wide association study , 2015 .

[16]  M. Bolognesi,et al.  TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy , 2015, Neurological Sciences.

[17]  A. Goate,et al.  Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.

[18]  M. Nishizawa,et al.  Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. , 2014, Stroke.

[19]  A. Hofman,et al.  Cerebral Microbleeds Are Associated with the Progression of Ischemic Vascular Lesions , 2014, Cerebrovascular Diseases.

[20]  R. Lakshmy,et al.  Synergistic Epistasis of Paraoxonase 1 (rs662 and rs85460) and Apolipoprotein E4 Genes in Pathogenesis of Alzheimer’s Disease and Vascular Dementia , 2014, American journal of Alzheimer's disease and other dementias.

[21]  G. Saposnik,et al.  Prevalence of Fabry disease in stroke patients--a systematic review and meta-analysis. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[22]  A. Federico,et al.  Two novel HTRA1 mutations in a European CARASIL patient , 2014, Neurology.

[23]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[24]  A. Roses,et al.  New applications of disease genetics and pharmacogenetics to drug development. , 2014, Current opinion in pharmacology.

[25]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[26]  D. Ryglewicz,et al.  Paraoxonase 1 (PON1) gene-108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia. , 2013, Folia neuropathologica.

[27]  K. Kohara,et al.  Association of Chr17q25 with cerebral white matter hyperintensities and cognitive impairment: the J‐SHIPP study , 2013, European journal of neurology.

[28]  Wiro J. Niessen,et al.  Changes in Normal-Appearing White Matter Precede Development of White Matter Lesions , 2013, Stroke.

[29]  Chaeyoung Lee,et al.  Association of intronic sequence variant in the gene encoding spleen tyrosine kinase with susceptibility to vascular dementia , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[30]  Jean-Claude Baron,et al.  Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  G. Deuschl,et al.  Acute Cerebrovascular Disease in the Young: The Stroke in Young Fabry Patients Study , 2013, Stroke.

[32]  N. Bresolin,et al.  Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy , 2012, Acta neurologica Scandinavica.

[33]  S. Debette,et al.  The genetics of small-vessel disease. , 2012, Current medicinal chemistry.

[34]  Y. Pi,et al.  Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: A meta-analysis , 2012, Neuroscience Letters.

[35]  A. Hofman,et al.  Genome-Wide Association Study of Vascular Dementia , 2012, Stroke.

[36]  M. Pirinen,et al.  Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke , 2012, Nature Genetics.

[37]  Benjamin F. J. Verhaaren,et al.  Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.

[38]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[39]  T. Fukutake.  Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. , 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[40]  S. Lanfranconi,et al.  COL4A1 Mutations as a Monogenic Cause of Cerebral Small Vessel Disease: A Systematic Review , 2010, Stroke.

[41]  Y. Qiu,et al.  The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis , 2010, Journal of the Neurological Sciences.

[42]  M. Fornage,et al.  Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium , 2010, Stroke.

[43]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[44]  M. Dichgans,et al.  CADASIL , 2009, The Lancet Neurology.

[45]  Ricardo J Komotar,et al.  Genomewide Association Studies of Stroke. , 2009, Neurosurgery.

[46]  S. Haller,et al.  Hereditary Systemic Angiopathy (HSA) with cerebral calcifications, retinopathy, progressive nephropathy, and hepatopathy , 2008, Journal of Neurology.

[47]  S. Nelson,et al.  C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.

[48]  L. Launer,et al.  A TGF-β1 polymorphism association with dementia and neuropathologies: The HAAS , 2007, Neurobiology of Aging.

[49]  J. Clarke.  Narrative Review: Fabry Disease , 2007, Annals of Internal Medicine.

[50]  Chaeyoung Lee,et al.  The Gene Encoding Transforming Growth Factor &bgr;1 Confers Risk of Ischemic Stroke and Vascular Dementia , 2006, Stroke.

[51]  S. Black,et al.  National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.

[52]  J. Kennedy,et al.  Pharmacogenetics in drug development , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.

[53]  Tan Xiao-mei,et al.  CADASIL , 2005 .

[54]  H. Fung,et al.  Heat Shock Protein 70 and Tumor Necrosis Factor Alpha in Taiwanese Patients with Dementia , 2005, Dementia and Geriatric Cognitive Disorders.

[55]  P. Amouyel,et al.  Paraoxonase 1 gene polymorphisms and dementia in humans , 2004, Neuroscience Letters.

[56]  H. Schmid,et al.  Evidence for systemic manifestations in cerebroretinal vasculopathy , 2003, American journal of medical genetics. Part A.

[57]  M. Cogné,et al.  Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[58]  Y. Lien,et al.  Biochemical and molecular genetic basis of Fabry disease. , 2002, Journal of the American Society of Nephrology : JASN.

[59]  G. Zuliani,et al.  Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia , 2001, Acta neurologica Scandinavica.

[60]  D. Middleton,et al.  Association between polymorphism in regulatory region of gene encoding tumour necrosis factor α and risk of Alzheimer's disease and vascular dementia: a case-control study , 2001, The Lancet.

[61]  G. Reifenberger,et al.  Cerebroretinal vasculopathy mimicking a brain tumor: A case of a rare hereditary syndrome , 1999, Neurology.

[62]  K. Engedal,et al.  The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. , 1997, Archives of general psychiatry.

[63]  Jia Sun,et al.  Genetics of Vascular Dementia: Systematic Review and Meta-Analysis. , 2015, Journal of Alzheimer's disease : JAD.

[64]  M. Munafo,et al.  Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment. , 2013, Journal of Alzheimer's disease : JAD.